VANGUARD ASSET MANAGEMENT, Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 1680208
London, EC4N 8AF, X0
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,734,754
+$2,403,330 QoQ
Shares Held
51,826
+7.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#165
of 768 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VANGUARD ASSET MANAGEMENT, Ltd holds $174,411,094 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
833,504 | $59,895,597 | |
| 2 | VTRS |
Viatris Inc
|
1,128,163 | $17,915,228 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
425,294 | $14,408,960 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
477,550 | $11,752,505 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
21,502 | $11,650,428 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
51,826 | $8,734,754 | |
| 7 | ALKS |
Alkermes plc.
|
157,759 | $8,266,571 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
196,860 | $6,825,136 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,734,754 | 51,826 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,331,424 | 48,060 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||